Richard A Scolyer
Richard A Scolyer
Melanoma Institute Australia, The University of Sydney, Royal Prince Alfred Hospital
Verified email at sswahs.nsw.gov.au - Homepage
Title
Cited by
Cited by
Year
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
14072015
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
10672018
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
GV Long, AM Menzies, AM Nagrial, LE Haydu, AL Hamilton, GJ Mann, ...
Journal of Clinical Oncology 29 (10), 1239-1246, 2011
10042011
Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ...
CA: a cancer journal for clinicians 67 (6), 472-492, 2017
922*2017
Cutaneous melanoma
JF Thompson, RA Scolyer, RF Kefford
The Lancet 365 (9460), 687-701, 2005
8632005
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
8472018
Pathology and genetics of skin tumours
PE LeBoit
IARC, 2006
8052006
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
7212018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
6552018
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma
CG Lian, Y Xu, C Ceol, F Wu, A Larson, K Dresser, W Xu, L Tan, Y Hu, ...
Cell 150 (6), 1135-1146, 2012
6522012
Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance
H Shi, G Moriceau, X Kong, MK Lee, H Lee, RC Koya, C Ng, T Chodon, ...
Nature communications 3 (1), 1-8, 2012
6412012
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
6332018
Whole-genome landscapes of major melanoma subtypes
NK Hayward, JS Wilmott, N Waddell, PA Johansson, MA Field, K Nones, ...
Nature 545 (7653), 175-180, 2017
5452017
Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma
JS Wilmott, GV Long, JR Howle, LE Haydu, RN Sharma, JF Thompson, ...
Clinical cancer research 18 (5), 1386-1394, 2012
5242012
Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center
MF Azzola, HM Shaw, JF Thompson, S Soong, RA Scolyer, GF Watson, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
4372003
Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma
F Azimi, RA Scolyer, P Rumcheva, M Moncrieff, R Murali, SW McCarthy, ...
Journal of clinical oncology 30 (21), 2678-2683, 2012
4362012
Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma
AM Menzies, LE Haydu, L Visintin, MS Carlino, JR Howle, JF Thompson, ...
Clinical cancer research 18 (12), 3242-3249, 2012
3922012
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
GV Long, V Atkinson, S Lo, S Sandhu, AD Guminski, MP Brown, ...
The Lancet Oncology 19 (5), 672-681, 2018
3882018
BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact
H Rizos, AM Menzies, GM Pupo, MS Carlino, C Fung, J Hyman, LE Haydu, ...
Clinical cancer research 20 (7), 1965-1977, 2014
3732014
The significance of the Wnt pathway in the pathology of human cancers
RZ Karim, GMK Tse, TC Putti, RA Scolyer, CS Lee
Pathology 36 (2), 120-128, 2004
3552004
The system can't perform the operation now. Try again later.
Articles 1–20